Streptokinase suppository - Heber Biotec

Drug Profile

Streptokinase suppository - Heber Biotec

Alternative Names: Proctokinase; rSK suppository - Heber Biotec

Latest Information Update: 05 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Center for Genetic Engineering and Biotechnology
  • Developer Center for Genetic Engineering and Biotechnology; Heber Biotec
  • Class Coenzymes; Plasminogen activator enzymes; Thrombolytics
  • Mechanism of Action Plasmin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Haemorrhoids

Most Recent Events

  • 31 Jul 2013 The Center for Genetic Engineering and Biotechnology and Heber Biotec complete the phase II THERESA-2 trial in Haemorrhoids in Cuba
  • 20 Dec 2010 Phase-II clinical trials in Haemorrhoids in Cuba (Rectal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top